Growth Services
Strategic insight for forward-thinking life science organizations
At CharaBio, we work with leading pharma, biotech firms, CDMOs, and investors to evaluate new markets, identify strategic opportunities, and make confident decisions that drive impact.
We don’t just consult—we partner with you to understand your vision, optimize your approach, and uncover the smartest paths to growth.
What We Do
We support senior leaders and innovation teams with:
Market Research & Competitive Intelligence
Understand where the market is heading—and where your company should go next.
Commercial Due Diligence
Rapidly assess acquisition targets with data-backed insights, expert interviews, and strategic evaluation.
Innovation & Portfolio Strategy
Identify new products, services, and business models that align with your growth ambitions.
Go-to-Market Strategy
Design scalable strategies for launching new technologies, services, or business units.
Custom Projects
Whether you need a rapid landscape scan or deep support for entering a new modality, we tailor our services to your needs.
Why Work With CharaBio?
- Deep domain expertise in advanced modalities like cell and gene therapy
- Global network of experts across pharma, biotech, and venture capital
- Flexible, founder-led approach—agile, precise, and collaborative
- Proven impact, including supporting $300M+ in strategic transactions
We also collaborate via Umbrex, a global network of top-tier consultants (90%+ McKinsey, BCG, Bain alumni), allowing us to scale teams with the right talent for every challenge.
“Thanks to Fabio and CharaBio’s support, we made data-driven decisions that led to high-impact investments in the cell therapy space.”
— CBO, Global CDMO